Xiaomin Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA modifications and cancer 11
- RNA Research and Splicing 5
- Ubiquitin and proteasome pathways 3
- Molecular Biology Techniques and Applications 3
- Natural product bioactivities and synthesis 3
-
- Cancer-related molecular mechanisms research 6
- Co-authors
- Zhenyu Yin (11 shared papers)Wenxiu Zhao (14 shared papers)Xiaoqin Chi (7 shared papers)Jinhao Gao (5 shared papers)Zhenghuan Zhao (4 shared papers)Chengrong Xie (9 shared papers)Xianglong Zhu (3 shared papers)Zhong Chen (3 shared papers)
- Journals
- Oncotarget (3 papers)Laboratory Investigation (2 papers)Drug Delivery (1 paper)Small (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaomin Wang
47 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 287
- Biomaterials 186
- Hepatology 91
- Molecular Biology 727
- Oncology 202
Countries citing papers authored by Xiaomin Wang
This map shows the geographic impact of Xiaomin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomin Wang more than expected).
Fields of papers citing papers by Xiaomin Wang
This network shows the impact of papers produced by Xiaomin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomin Wang. The network helps show where Xiaomin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaomin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 140 | |
| 2 | 2009 | 124 | |
| 3 | 2017 | 117 | |
| 4 | 2015 | 113 | |
| 5 | 2022 | 94 | |
| 6 | 2020 | 85 | |
| 7 | 2015 | 77 | |
| 8 | 2017 | 72 | |
| 9 | 2013 | 61 | |
| 10 | 2014 | 54 | |
| 11 | 2012 | 53 | |
| 12 | 2019 | 43 | |
| 13 | 2012 | 43 | |
| 14 | 2019 | 39 | |
| 15 | 2012 | 38 | |
| 16 | 2018 | 35 | |
| 17 | 2013 | 32 | |
| 18 | 2014 | 32 | |
| 19 | 2016 | 28 | |
| 20 | 2012 | 25 |
About Xiaomin Wang
Xiaomin Wang is a scholar working on Molecular Biology, Cancer Research, Cell Biology, Immunology and Hepatology, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (6 papers), RNA Research and Splicing (5 papers), Ubiquitin and proteasome pathways (3 papers), Liver physiology and pathology (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Molecular Biology Techniques and Applications (3 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Cancer Research (287 citations), Biomaterials (186 citations), Hepatology (91 citations), Molecular Biology (727 citations) and Oncology (202 citations). Xiaomin Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhenyu Yin, Wenxiu Zhao, Xiaoqin Chi, Jinhao Gao, Zhenghuan Zhao, Chengrong Xie, Xianglong Zhu, Zhong Chen, Qiao Wu and Penghao Kuang. Their work appears in journals such as Oncotarget, Laboratory Investigation, Drug Delivery, Small and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.